awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q59236731-813D20ED-EC48-4ED2-997D-40AA567BC6B9
Q59236731-813D20ED-EC48-4ED2-997D-40AA567BC6B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59236731-813D20ED-EC48-4ED2-997D-40AA567BC6B9
Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity
P356
Q59236731-813D20ED-EC48-4ED2-997D-40AA567BC6B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59236731-813D20ED-EC48-4ED2-997D-40AA567BC6B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
842f0bd6ac1f8b9174b9274a2012166bee5c17a3
P356
10.1182/BLOOD-2007-06-093617
http://www.w3.org/2001/XMLSchema#string
P356
BLOOD-2007-06-093617